News and Events
- Network Profile
- Press Release
- Research Highlight
By Chardelle Prevatt The Canadian Glycomics Network (GlycoNet) is delighted to announce the strengthening of its collaboration with Alberta Innovates Technology Futures (AITF). GlycoNet has …
Two new studies led by U of G researchers showing novel ways used by pathogens to make and attach protective cell coats might open a route to new drugs for penetrating those defences and treating often-serious infections.
GlycoNet Network Investigator Dr. Lynne Howell and her team at The Hospital for Sick Children are developing new methods to break down the wall that protects bacteria against current therapeutic interventions.
Carbohydrate synthesis, glycan structure analysis, and library screening are the core services being offered by GlycoNet, in partnership with the Alberta Glycomics Centre.
A summary of GlycoNet Network Investigators Eric Brown and Gerard Wright’s recently published work “Antibacterial drug discovery in the resistance era”
The GlycoNet Trainee Association Executive Committee is established to discuss ways the Network can help support the next generation of Canadian glycomics scientists.
Collaboration between two GlycoNet researchers has led to the discovery of a novel class of enzymes and an increased understanding of how to potentially fight a common and deadly fungal infection.
GlycoNet researcher Donald Sheppard, from the Research Institute of the McGill University Health Centre in Montreal, Canada, and colleagues set out to explore features that could facilitate infection by A. fumigatus as compared with less pathogenic Aspergillus species.